Skip to main content

Advertisement

SpringerLink
Log in

Ecopharmacovigilance for Better Health

  • Editorial
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Gore A. Moving beyond Kyoto. The New York Times 2007 Jul 1 [online]. Available from URL: http://www.nytimes.com/2007/07/01/opinion/01gore.html [Accessed 2010 Jun 16]

  2. Edwards IR, Hugman B, Lindquist M, et al. Erice Statement 2009: communication, medicines and patient safety. Br J Clin Pharmacol 2010; 69(2): 207–8

    Article  Google Scholar 

  3. Wise R. Antimicrobial resistance: priorities for action. Antimicrob Chemother 2002; 49: 585–6

    Article  CAS  Google Scholar 

  4. Ternes T, Giger W, Joss A. Introduction in human pharmaceuticals, hormones and fragrances. In: Ternes T, Joss A, editors. The challenge of micropollutants in urban water management. IWA Publishing, 2007: 1–14

  5. Kühler TC, Andersson M, Carlin G, et al. Do biological medicinal products pose a risk to the environment? A current view on ecopharmacovigilance. Drug Saf 2009; 32(11): 995–1000

    Article  PubMed  Google Scholar 

  6. Tysklind M, Fick J, Kallenborn R. The spread of drugs in soil and water. In: Collaboration between Apoteket AB, Stockholm County Council and Stockholm University. Environment and pharmaceuticals. Apoteket AB, 2006: 41–53 [online]. Available from URL: http://www.janusinfo.se/imcms/servlet/GetDoc?meta_id=9564 [Accessed 2010 Jun 16]

  7. Kummerer K. Pharmaceuticals in the environment. 3rd ed. Berlin, Heidelberg: Springer-Verlag, 2008

    Book  Google Scholar 

  8. Kummerer K. Resistance in the environment. J Antimicrob Chemother 2004; 54: 311–20

    Article  PubMed  CAS  Google Scholar 

  9. D’Costa VM, McGrann KM, Hughes DW, et al. Sampling in the antibiotic resistome. Science 2006; 311: 374–7

    Article  PubMed  Google Scholar 

  10. Zuccato E, Calamari D, Natangelo M, et al. Presence of therapeutic drugs in the environment. Lancet 2000; 355: 1789–90

    Article  PubMed  CAS  Google Scholar 

  11. Zuccato E, Chiabrando C, Castiglioni S, et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health 2005 Aug 5; 4: 14–20

    Article  PubMed  Google Scholar 

  12. Heberer T. Occurrence, fate, and removal of pharmaceuticals residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002; 131: 5–17

    Article  PubMed  CAS  Google Scholar 

  13. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 2002; 36: 1202–11

    Article  PubMed  CAS  Google Scholar 

  14. Dove A. Drugs down the drain. Nat Med 2006; 12(4): 376–7

    Article  PubMed  CAS  Google Scholar 

  15. Stan H, Heberer T, Linkerhagner M. Occurrence of clofibric acid in the aquatic system: is the use in human medical care the source of the contamination of surface, ground, and drinking water? Vom Wasser 1994; D 83: 57–68

    CAS  Google Scholar 

  16. Ternes TA. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. Trends Anal Chem 2001; 20: 419–33

    Article  CAS  Google Scholar 

  17. Ye Z, Weinberg HS, Meyer MT. Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry. Anal Chem 2007; 79(3): 1135–44

    Article  PubMed  CAS  Google Scholar 

  18. Jones OA, Lester JN, Voulvonis N. Pharmaceuticals: a threat to drinking water? Trends Biotechnol 2005; 23(4): 163–7

    Article  PubMed  CAS  Google Scholar 

  19. Carlsen E, Giwercman A, Keiding N, et al. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305: 609–13

    Article  PubMed  CAS  Google Scholar 

  20. Sherins RJ. Are semen quality and male fertility changing? N Engl J Med 1995; 332(5): 327–8

    Article  PubMed  CAS  Google Scholar 

  21. Auger J, Kunstmann JM, Czyglik F, et al. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332: 281–5

    Article  PubMed  CAS  Google Scholar 

  22. Knudsen FR, Schou AE, Wiborg ML, et al. Increase of plasma vitellogenin concentration in rainbow trout (Oncorhynchus mykiss) exposed to effluents from oil refinery treatment works and municipal sewage. Bull Environ Contam Toxicol 1997; 59: 802–6

    Article  PubMed  CAS  Google Scholar 

  23. Oaks JL, Gilbert M, Virani MZ, et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004; 427: 630–3

    Article  PubMed  CAS  Google Scholar 

  24. Liney KE, Jobling S, Shears JA, et al. Assessing the sensitivity of different life stages for sexual disruption in roach (Rutilus rutilus) exposed to effluents from wastewater treatment works. Environ Health Perspect 2005; 113(10): 1299–307

    Article  PubMed  CAS  Google Scholar 

  25. Boxall ABA. The environmental side effects of medication: how are human and veterinary medicines in soils and water bodies affecting human and environmental health? EMBO Rep 2004; 5(12): 1110–6

    Article  PubMed  CAS  Google Scholar 

  26. European Commission. Communication from the European Commission on the precautionary principle. Brussels; 2000 Feb 02 [online]. Available from URL: http://ec.europa.eu/environment/docum/20001_en.htm [Accessed 2010 Jun 16]

  27. Stockholm County Council. Environmentally classified pharmaceuticals 2010 [online]. Available from URL: http://www.janusinfo.se/Global/Miljo%20och%20lakemedel/miljo_broschyr_eng2010.pdf [Accessed 2010 Jun 16]

  28. Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the community code relating to veterinary medicinal products [online]. Available from URL: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32004L0028:EN:HTML [Accessed 2010 Jul 19]

  29. Kümmerer K, Velo G. Ecopharmacology: a new topic of importance in pharmacovigilance. Drug Saf 2006; 29(5): 371–3

    Article  PubMed  Google Scholar 

  30. Liikanen E. Review of the pharmaceutical legislation. Speech/03/615 at the European Parliament Plenary Session, Strasbourg; 2003 Dec 16

  31. European Commission. Safe, innovative and accessible medicines: a renewed vision for the pharmaceutical sector, 2008 Dec 10 [online]. Available from URL: http://ec.europa.eu/health/human-use/package_en.htm [Accessed 2010 Jun 16]

  32. Carlsson C, Johansson AK, Alvan G, et al. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 2006; 364: 67–87

    Article  PubMed  CAS  Google Scholar 

  33. Press Release of US Senator Kirsten E. Gillibrand, 2009 May 14 [online]. Available from URL: http://gillibrand.senate.gov/newsroom/press/release/?id=a19ef6cc-59e9-4ec1-994d-86ae56f1628e [Accessed 2010 Jun 16]

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this editorial and the authors have no conflicts of interest that are directly relevant to its content.

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, University Hospital of Verona, Pharmacovigilance Centre of Veneto Region, Reference Centre for Education and Communication within the WHO Programme for International Drug Monitoring, Policlinico G.B. Rossi, P.le L.A. Scuro 10, 37134, Verona, Italy

    Giampaolo Velo & Ugo Moretti

Authors
  1. Giampaolo Velo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ugo Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giampaolo Velo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Velo, G., Moretti, U. Ecopharmacovigilance for Better Health. Drug-Safety 33, 963–968 (2010). https://doi.org/10.2165/11539380-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11539380-000000000-00000

Search

Navigation